Keyphrases
Scotland
100%
Tayside
99%
Clinical Trials
87%
Intracerebral Hemorrhage
65%
Confidence Interval
63%
Primary Care
55%
Record Linkage
52%
Prucalopride
52%
Indapamide
49%
Major Adverse Cardiovascular Events
48%
Ischemic Stroke
45%
Hypertension
44%
Population-based Cohort Study
40%
Pharmacoepidemiology
39%
Hazard Ratio
38%
Bendroflumethiazide
37%
Diuretics
35%
Mortality Outcomes
34%
Label Change
34%
Disease Severity
34%
Follow-up Rate
34%
Antiplatelet
34%
Long-term Mortality
34%
Retention Rate
34%
Cardiovascular Disease
34%
Diclofenac
34%
Prescribing Policy
34%
During Pregnancy
34%
Cluster Randomized Trial
34%
Chronic Obstructive Pulmonary Disease
34%
Thiazide Diuretics
34%
Linkage Analysis
34%
Standardized Incidence Ratio
34%
Hospitalization
32%
Electronic Data Capture
31%
Polyethylene Glycol 3350
31%
Hyperthyroidism
30%
Dysrhythmia
27%
Cardiovascular Outcomes
27%
European Medicines Agency
26%
Netherlands
26%
Comparative Effectiveness
26%
Cardiovascular Safety
24%
Evening Dosing
24%
All-cause Mortality
24%
Denmark
23%
Free Text
23%
European Union
23%
Functional Constipation
22%
Survival Analysis
22%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
99%
Cerebrovascular Accident
79%
Cardiovascular Disease
70%
Brain Hemorrhage
53%
Prucalopride
52%
Indapamide
48%
Bendroflumethiazide
37%
Thiazide Diuretic Agent
35%
Diuretics
35%
Thyroid Disease
34%
Chronic Obstructive Lung Disease
34%
Pharmacoepidemiology
34%
Diclofenac
34%
Antiplatelet
34%
Heart Infarction
33%
Macrogol 3350
32%
Hypothyroidism
31%
Clinical Trial
29%
Brain Ischemia
28%
Hyperthyroidism
26%
Prevalence
25%
Chronic Constipation
24%
Antihypertensive Therapy
21%
All Cause Mortality
21%
Non-Steroidal Anti-Inflammatory Drug
20%
Disease Severity
17%
Genetic Risk
17%
Antihypertensive Agent
17%
Thyroxine
17%
Thyrotropin
17%
Major Adverse Cardiac Event
17%
Zofran
17%
Cluster Randomized Trial
17%
Pain Medicine
17%
Antacid Agent
17%
Anticoagulant Agent
17%
Nausea and Vomiting
17%
Gastroenteritis
17%
Pharmacovigilance
17%
Primary Hyperparathyroidism
17%
Codeine
17%
Cataract
17%
Antihypertensive
17%
Brain Infarction
17%
Modified Release
17%
Standardized Incidence Ratio
16%
Acetylsalicylic Acid
13%
Antiemetic Agent
13%
Folic Acid
13%
Campylobacter
13%
Medicine and Dentistry
Medicine
46%
Primary Health Care
40%
Apoplexy
40%
Cardiovascular System
40%
Clinical Trial
37%
Cerebral Hemorrhage
36%
Prucalopride
34%
Chronic Obstructive Pulmonary Disease
34%
Pharmacoepidemiology
34%
Thiazide Diuretic Agent
34%
Diuretics
34%
Macrogol
20%
Bendroflumethiazide
19%
Cohort Analysis
19%
Hospital Inpatient
19%
Cardiovascular Disease
18%
Brain Ischemia
18%
Chronic Kidney Disease
17%
Allopurinol
17%
Linkage Analysis
17%
Cluster Randomized Trial
17%
Acute Kidney Injury
17%
Disease Severity
17%
Dyspnea
17%
Survival Analysis
17%
Radiology
17%
Medical Informatics
17%
Airway Obstruction
17%
Antithrombotic
17%
Diabetes
17%
Febuxostat
17%
Mass Immunization
17%
Gastroenteritis
17%
Alternative Medicine
17%
Codeine
17%
Systematic Review
17%
COVID-19 Vaccine
17%
Comorbidity
17%
Gene Linkage
17%
Indapamide
14%
Hazard Ratio
11%
Patient Referral
11%
National Health Service
11%
Adverse Event
10%
Renal Replacement Therapy
10%
Odds Ratio
10%
Clinical Research
10%
Health Care Cost
10%
Division
10%
Campylobacter
10%